参考文献/References:
[1] YANG Y,LU C,LI L,et al.Construction and multicohort validation of a colon cancer prognostic risk score system based on big data of neutrophil-associated differentially expressed genes[J].J Cancer,2024,15(9):2866-2879.
[2] 孟祥彩,刘洋,武玉,等.黄芩素在伊立替康抑制结肠癌细胞增殖中的作用研究[J].陕西中医,2022,43(12):1682-1685.
[3] WANG C,GAO Z,SHEN Z,et al.Five-year prognosis of complete mesocolic excision in patients with colon cancer:A prospective,nonrandomized,double-blind controlled trial[J].J Am Coll Surg,2022,235(4):666-676.
[4] TAKAKI W,ARITA T,KURIU Y,et al.Impact of the preoperative clinical N stage on the prognosis of patients with colon cancer[J].Colorectal Dis,2023,25(2):243-252.
[5] MA S,HUANG Z,CHEN Q,et al.Effect of cichoric acid on colorectal cancer:Impact on migration,epithelial-mesenchymal transition,and proliferation via RhoA/ROCK signaling pathway modulation[J].Discov Med,2024,36(180):190-198.
[6] ZHAO L,REN C,FANG Y,et al.MiR-490-3p sponged by lncRNA NEAT1 can attenuate lung adenocarcinoma progression by suppressing the RhoA/ROCK signaling pathway[J].Ann Clin Lab Sci,2023,53(1):42-51.
[7] KOMATSU M,ICHIKAWA H,CHIWAKI F,et al.ARHGAP-RhoA signaling provokes homotypic adhesion-triggered cell death of metastasized diffuse-type gastric cancer[J].Oncogene,2022,41(43):4779-4794.
[8] SUN S,XU K,YAN M,et al.Delphinidin induces autophagic flux blockage and apoptosis by inhibiting both multidrug resistance gene 1 and DEAD-box helicase 17 expressions in liver cancer cells[J].J Pharm Pharmacol,2023,75(2):253-263.
[9] PENG J,WU A,YU X,et al.Combined network pharmacology and cytology experiments to identify potential anti-breast cancer targets and mechanisms of delphinidin[J].Nutr Cancer,2022,74(7):2591-2606.
[10] 叶乐乐,于德新.飞燕草素对人膀胱癌T24细胞增殖、凋亡的影响及机制研究[J].中国现代应用药学,2021,38(4):409-414.
[11] 国家卫生健康委员会医政司,中华医学会肿瘤学分会.国家卫健委中国结直肠癌诊疗规范(2023版)[J].中国实用外科杂志,2023,43(6):602-630.
[12] LIU L,MO M,CHEN X,et al.Targeting inhibition of prognosis-related lipid metabolism genes including CYP19A1 enhances immunotherapeutic response in colon cancer[J].J Exp Clin Cancer Res,2023,42(1):85-104.
[13] 王江业,张倍宁,孙国良,等.温阳扶正方治疗晚期结肠癌脾肾阳虚证临床研究[J].陕西中医,2024,45(2):196-199.
[14] 李小坤,冯杰,张星星,等.飞燕草素调节Numb/Notch信号通路诱导卵巢癌细胞凋亡[J].解剖学研究,2023,45(3):251-257.
[15] PIENKOWSKA N,BARTOSZ G,FURDAK P,et al.Delphinidin increases the sensitivity of ovarian cancer cell lines to 3-bromopyruvate[J].Int J Mol Sci,2021,22(2):709-730.
[16] ZHANG Z,PAN Y,ZHAO Y,et al.Delphinidin modulates JAK/STAT3 and MAPKinase signaling to induce apoptosis in HCT116 cells[J].Environ Toxicol,2021,36(8):1557-1566.
[17] HSU W H,LABELLA K A,LIN Y,et al.Oncogenic KRAS drives lipofibrogenesis to promote angiogenesis and colon cancer progression[J].Cancer Discov,2023,13(12):2652-2673.
[18] HUANG C,LI H,XU Y,et al.BICC1 drives pancreatic cancer progression by inducing VEGF-independent angiogenesis[J].Signal Transduct Target Ther,2023,8(1):271.
[19] 戚新春,易建华.长链非编码RNA BCYRN1对脑胶质瘤大鼠HIF-1α/VEGF信号通路和血管生成的作用机制[J].陕西医学杂志,2023,52(4):376-379.
[20] LI X,LI Z,LI C,et al.Contrast-enhanced ultrasound for the evaluation of CXCR7-mediated angiogenesis in colon cancer[J].J Cancer,2023,14(4):665-675.
[21] YANG Y,LI L,HE H,et al.Numb inhibits migration and promotes proliferation of colon cancer cells via RhoA/ROCK signaling pathway repression[J].Exp Cell Res,2022,411(2):113004.
[22] 张薇,陈姣敏,许卫星,等.苍术素调节RhoA/ROCK信号通路对弥漫大B细胞淋巴瘤细胞恶性生物学行为的影响[J].陕西医学杂志,2024,53(5):593-597.
[23] 赵馨,尹健,贾彤.利多卡因调节RhoA/ROCK轴对结直肠癌细胞生物学行为的影响[J].中国细胞生物学学报,2024,46(3):466-476.
[24] LI X,LI D,MA R.ALW-Ⅱ-41-27,an EphA2 inhibitor,inhibits proliferation,migration and invasion of cervical cancer cells via inhibition of the RhoA/ROCK pathway[J].Oncol Lett,2022,23(4):129.
[25] DING A X,WANG H,ZHANG J M,et al.LncRNA BANCR promotes the colorectal cancer metastasis through accelerating exosomes-mediated M2 macrophage polarization via regulating RhoA/ROCK signaling[J].Mol Cell Biochem,2024,479(1):13-27.
相似文献/References:
[1]王 雄,张月飞,赵东雄,等.初诊结肠癌患者血小板相关指标与临床分期关系分析[J].陕西医学杂志,2019,(12):1676.
[2]龚 磊,吕真冰,喻 晶,等.SIRT1、Phospho-SIRT1在结肠癌组织中的表达及临床意义*[J].陕西医学杂志,2020,49(3):274.
GONG Lei,LV Zhenbing,YU Jing,et al.Expression and clinical significance of SIRT1 and Phospho-SIRT1 in colon cancer tissues[J].,2020,49(11):274.
[3]冯 婷,刘 霞,高立勇.叉头框转录因子O亚族3a对结肠癌SW620细胞的影响及机制研究[J].陕西医学杂志,2021,50(9):1068.[doi:DOI:10.3969/j.issn.1000-7377.2021.09.007]
FENG Ting,LIU Xia,GAO Liyong.Effect and mechanism of FOXO3a on colon cancer SW620 cells[J].,2021,50(11):1068.[doi:DOI:10.3969/j.issn.1000-7377.2021.09.007]
[4]顾 勇,杨 艳,符 翠,等.白藜芦醇对结肠癌恶性生物学行为的抑制作用研究[J].陕西医学杂志,2021,50(9):1072.[doi:DOI:10.3969/j.issn.1000-7377.2021.09.008]
GU Yong,YANG Yan,FU Cui,et al.Inhibitory effect of resveratrol on malignant biological behavior of colon cancer[J].,2021,50(11):1072.[doi:DOI:10.3969/j.issn.1000-7377.2021.09.008]
[5]余 亮,郭 建,周国强,等.结肠癌患者血清微小RNA-193a-5p和微小RNA-139-5p表达检测及其对预后的影响[J].陕西医学杂志,2023,52(6):745.[doi:DOI:10.3969/j.issn.1000-7377.2023.06.024]
YU Liang,GUO Jian,ZHOU Guoqiang,et al.Expression of serum miR-193a-5p and miRNA-139-5p in patients with colon cancer and their effects on prognosis[J].,2023,52(11):745.[doi:DOI:10.3969/j.issn.1000-7377.2023.06.024]
[6]徐 敏,王彦舟,张 华.全身炎性反应指数联合控制营养状况评分对结肠癌患者预后的预测价值[J].陕西医学杂志,2023,52(11):1558.[doi:DOI:10.3969/j.issn.1000-7377.2023.11.023]
XU Min,WANG Yanzhou,ZHANG Hua.Predictive value of SIRI combined with CONUT score in prognosis of patients with colon cancer[J].,2023,52(11):1558.[doi:DOI:10.3969/j.issn.1000-7377.2023.11.023]
[7]王瑜崴,李 濛,康 博,等.结肠癌组织微小RNA-3607-3p、细胞周期蛋白E2表达及其与患者术后5年预后关系研究[J].陕西医学杂志,2024,(8):1124.[doi:DOI:10.3969/j.issn.1000-7377.2024.08.026]
WANG Yuwei,LI Meng,KANG Bo,et al.Expression of microRNA-3607-3p and cyclin E2 in colon cancer tissues and their relationship with 5-year prognosis of patients after surgery[J].,2024,(11):1124.[doi:DOI:10.3969/j.issn.1000-7377.2024.08.026]